• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN)].

作者信息

Fritze J, Schmauss M

出版信息

Nervenarzt. 2003 Jan;74(1):97-9.

PMID:12685448
Abstract
摘要

相似文献

1
[Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN)].[全国医师与健康保险商委员会关于非典型抗精神病药物的指南变更。德国精神病学、心理治疗与神经病学协会（DGPPN）声明]
Nervenarzt. 2003 Jan;74(1):97-9.
2
[Statement of the DGPPN on the key policy points of the German Federal Ministry of Health and Social Security with regard to modernization of the health care system].[德国精神病学、心理治疗与神经病学专业协会关于德国联邦卫生与社会保障部医疗保健系统现代化关键政策要点的声明]
Nervenarzt. 2003 Apr;74(4):391-3.
3
[Pro and contra: basic precedence of atypical neuroleptics].[支持与反对：非典型抗精神病药物的基本优先性]
Psychiatr Prax. 2005 May;32(4):163-6. doi: 10.1055/s-2004-834708.
4
[Comments on the position paper of the DGPPN (German Society of Psychiatry, Psychotherapy and Neurology].
Nervenarzt. 1998 Jan;69(1):89-91.
5
[Comment on the S3 Guidelines Dementia by the DGPPN and the DGN from the neurological point of view].[德国神经病学专业协会和德国神经病学学会对痴呆症S3指南的神经学视角评论]
Fortschr Neurol Psychiatr. 2010 Sep;78(9):504-8. doi: 10.1055/s-0029-1245469. Epub 2010 Sep 8.
6
[CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Psychiatr Prax. 2007 Jul;34(5):255-7. doi: 10.1055/s-2007-984998.
7
Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.非典型与典型抗精神病药物治疗精神分裂症在常规护理中的有效性及成本
J Ment Health Policy Econ. 2008 Jun;11(2):89-97.
8
[The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].[抗精神病药物对精神分裂症患者住院治疗发生率及费用的影响：一项前瞻性观察性研究的结果]
Psychiatr Prax. 2004 Apr;31(3):138-46. doi: 10.1055/s-2003-812599.
9
[Psychosocial intervention in schizophrenia or schizophrenia-like conditions. A life as normal as possible--the target in new national guidelines].[精神分裂症或精神分裂症样疾病的心理社会干预。尽可能正常的生活——新国家指南中的目标]
Lakartidningen. 2011;108(35):1627-30.
10
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Encephale. 2009 Jan;Suppl 3:S91-5. doi: 10.1016/S0013-7006(09)75543-5.

引用本文的文献

1
[Cost predictors of depressive inpatient episodes in Germany. The health insurer's point of view].[德国抑郁症住院发作的费用预测因素。健康保险公司的视角]
Nervenarzt. 2007 Jun;78(6):665-71. doi: 10.1007/s00115-006-2115-x.
2
[Differential indications for atypical neuroleptics: Amisulprid, Clozapin, Olanzapin, Quetiapin und Risperidon. Results of a pilot study of prescription habits in psychiatric clinical usage in the BRD].
Nervenarzt. 2005 Mar;76(3):278-84. doi: 10.1007/s00115-004-1795-3.